Abstract:PURPOSE:PNAS-4, a novel pro-apoptotic gene activated during the early response to DNA damage, can inhibit proliferation via apoptosis when overexpressed in some tumor cells. The objectives of this study were to determine whether PNAS-4 could enhance apoptosis induced by cisplatin besides its induction of apoptosis, and to evaluate the usefulness of combined treatment with mouse PNAS-4 (mPNAS-4) gene therapy and low-dose cisplatin chemotherapy in the inhibition of tumor growth in colon carcinoma (CT26) and Lewis lung carcinoma (LL/2) murine models.METHODS:In this study, the in vitro growth-inhibitory and pro-apoptotic effects of PNAS-4 and/or cisplatin on CT26, LL/2, and SKOV3 cancer cells were assessed by MTT assay, flow cytometric analysis, DNA fragmentation, and morphological analysis, respectively. The in vivo antitumor activity of combined treatment with mPNAS-4 gene therapy and low-dose cisplatin were evaluated in the inhibition of tumor growth in colon carcinoma (CT26) and Lewis lung carcinoma (LL/2) murine models. Tumor volume and survival time were observed. Induction of apoptosis was also assessed in tumor tissues.RESULTS:In vitro, PNAS-4 inhibited proliferation of colon carcinoma (CT26), Lewis lung carcinoma (LL/2) and human ovarian cancer (SKOV3) cell lines via apoptosis, and significantly enhanced the apoptosis of CT26, LL/2, and SKOV3 cells induced by cisplatin. In vivo systemic administration of expression plasmid encoding mPNAS-4 (pcDNA3.1-mPS) and cisplatin, significantly decreased tumor growth through increased tumor cell apoptosis compared to treatment with mPNAS-4 or cisplatin alone.CONCLUSIONS:Our data suggests that the combined treatment with mPNAS-4 plus cisplatin may augment the induction of apoptosis in tumor cells in vitro and in vivo, and that the augmented antitumor activity in vivo may result from the increased induction of apoptosis. The present study may provide a novel way to augment the antitumor efficacy of cytotoxic chemotherapy.

A Novel Pro-Apoptosis Gene Pnas4 That Induces Apoptosis in A549 Human Lung Adenocarcinoma Cells and Inhibits Tumor Growth in Mice

PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells

PNAS-4, a Novel Pro-Apoptotic Gene, Can Potentiate Antineoplastic Effects of Cisplatin

Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer.

[Construction and Expression of Eukaryotic Expression Vector of a Novel Apoptosis-Related Mouse Gene, Mpnas-4 and Its Antitumor Activity in Vitro].

Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model

Altered Protein-Expressing Profile in Hpnas4-Induced Apoptosis in A549 Human Lung Adenocarcinoma Cells

Research Progress of a Novel Pro-apoptosis Gene PNAS-4 in Gene Therapy and Its Molecular Mechanism Hypotheses

Improved Therapeutic Efficacy Against Murine Carcinoma By Combining Honokiol With Gene Therapy Of Pnas-4, A Novel Pro-Apoptotic Gene

Pnas-4 Expression and Its Relationship to P53 in Colorectal Cancer

hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells

AOC4P Suppresses Viability and Invasion and Induces Apoptosis in NSCLC Cells by Inhibiting the Wnt/β-catenin Pathway.

A Novel Compound RY10-4 Induces Apoptosis and Inhibits Invasion Via Inhibiting STAT3 Through ERK-, P38-Dependent Pathways in Human Lung Adenocarcinoma A549 Cells

PNAS-2: a novel gene probably participating in leukemogenesis.

4-HPR Effects on Apoptosis of A549 in Vitro Through Changing Bcl-2 Family Protein Expression

Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma

Human Α-Defensin-1 Inhibits Growth of Human Lung Adenocarcinoma Xenograft in Nude Mice

Construction of recombinant adenovirus vector carrying hPNAS-4 and its anti-tumor activity in vitro

Mir-421 Induces Cell Proliferation and Apoptosis Resistance in Human Nasopharyngeal Carcinoma Via Downregulation of Foxo4

Ing4 induces Cell Growth Inhibition in Human Lung Adenocarcinoma A549 Cells by Means of Wnt‐1/β‐Catenin Signaling Pathway

Exogenous P53 Upregulated Modulator of Apoptosis (PUMA) Decreases Growth of Lung Cancer A549 Cells